| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.028 | 0.9 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |